With all the challenges facing the healthcare world, Methodist Health System Foundation has achieved a major hurdle. It’s just completed its year-long $3.5M capital campaign for the Dr. Stephen and Marilyn Mansfield Oncology Unit at Methodist Charlton Medical Center.
Scheduled to open next year, the new facility will “nearly double the capacity of patients treated each year and centralize oncology care at Methodist Charlton.”
With Methodist Charlton’s “primary service area being Cedar Hill, DeSoto, Duncanville, Lancaster and southern Dallas,” the need for the expansion of oncology services was enhanced by “Susan G. Komen Dallas County’s most recent community profile as consistently experiencing the highest rates of breast cancer death in the Dallas area.”
According to Methodist Charlton President Fran Laukaitis, “Cancer is a real issue in the southern sector of Dallas, especially breast cancer. To combat this disparity effectively, it was clear that, in addition to our community education programs and outreach efforts, we needed a dedicated oncology unity.”
The unit’s naming was a secret undertaking by the Methodist Health System Board of Directors.
As Board Chair Julie Yarbrough explained, “Naming the unit the Dr. Stephen and Marilyn Mansfield Oncology Unit at Methodist Charlton honors a man who made an immeasurable contribution to the health and wellness of this community during his tenure as president and CEO of Methodist Health System.”
Helping to achieve the capital campaign’s goal were such donors as Katherine Carmody Trust, Bank of America, N.A., Trustee; Community Impact Fund of The Dallas Foundation; Nita and John R. Ford; Nancy Ann and Ray L. Hunt; Brenda L. Jackson; Oncor; Hesta Stuart Christian Charitable Trust plus proceeds from the 2018 Robert S. Folsom Leadership Award honoring Sen. Royce West.